TAGLN2 and glioblastoma: The results revealed that TAGLN2 was broadly expressed in various cancer types, with significantly increased expression especially in tumor tissues of GBM (Glioblastoma Multiforme), CHOL (Cholangiocarcinoma), and ESCA (Esophageal Carcinoma) compared to normal tissues.